Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04908709 · ClinicalTrials.gov registry record · NA
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
A NA study of Malignant Brain Glioma, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 3
- Study locations
NCT04908709 is a NA study of Malignant Brain Glioma that is actively recruiting participants, run by Emory University. The registered enrollment target is 25 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT04908709, a NA study of Malignant Brain Glioma, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 3
- Study locations
Study Summary
This trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, such as spectroscopic MRI may help to map the differences in tumor metabolism compared to healthy tissue without injection of any contrast agent.
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- DEVICE Proton Therapy
Study Locations (3)
Georgia
- Emory Proton Therapy Center - Atlanta
- Children's Healthcare of Atlanta - Scottish Rite - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2030-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04908709
The ClinicalTrials.gov registry entry for NCT04908709 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Brain Glioma appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Spectroscopic Imaging is the first listed.
NCT04908709 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04908709 about?
NCT04908709 is a clinical study titled "Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors". This trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, such as spectroscopic MRI may help to map the differences in tumor metabolism compared to healthy ti...
What is the current status of trial NCT04908709?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2018-12-20. Estimated completion is 2030-10-13.
What conditions does trial NCT04908709 study?
This clinical trial studies the following conditions: Malignant Brain Glioma.
What interventions are being tested in trial NCT04908709?
The interventions under investigation include: Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Proton Therapy (DEVICE).
Who is sponsoring clinical trial NCT04908709?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04908709 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Brain Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.